Nuvectis Pharma Inc (NVCT)
6.62
-0.05
(-0.75%)
USD |
NASDAQ |
May 23, 16:00
6.62
0.00 (0.00%)
After-Hours: 20:00
Nuvectis Pharma Total Assets (Quarterly): 19.71M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 19.71M |
| December 31, 2023 | 19.18M |
| September 30, 2023 | 22.26M |
| June 30, 2023 | 24.94M |
| March 31, 2023 | 16.21M |
| December 31, 2022 | 20.40M |
| Date | Value |
|---|---|
| September 30, 2022 | 24.87M |
| June 30, 2022 | 14.24M |
| March 31, 2022 | 17.62M |
| December 31, 2021 | 6.657M |
| September 30, 2021 | 6.809M |
| June 30, 2021 | 7.214M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.657M
Minimum
Dec 2021
24.94M
Maximum
Jun 2023
16.68M
Average
18.40M
Median
Total Assets (Quarterly) Benchmarks
| Schrodinger Inc | 737.76M |
| CEL-SCI Corp | 30.05M |
| AIM ImmunoTech Inc | 16.19M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 5.357M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.692M |
| Shareholders Equity (Quarterly) | 14.02M |